Vilin Bio Med IPO GMP, Grey Market Premium Today

Check out Vilin Bio Med IPO GMP aka IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates as of today. Vilin Bio Med IPO GMP not started yet. Stay tuned for the latest IPO GMP numbers of Vilin Bio Med IPO.
Vilin Bio Med IPO

Table of Contents

Vilin Bio Med IPO is to open on June 16. The company is to raise ₹12 crores via IPO. Vilin Bio Med Limited is a manufacturer of pharmaceuticals formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta, and Non-Beta Lactam tablets and Capsules & Nutritional Food supplements. The company reported revenue of ₹11.22 crores in 2022 against revenues of ₹11.72 crores in 2021. The IPO price band is fixed at ₹30 Per Equity Share. The Vilin Bio Med IPO to list on NSE.


What is Vilin Bio Med IPO GMP Today?

The Vilin Bio Med IPO GMP aka Grey Market Premium is ₹-.


What is Vilin Bio Med IPO Kostak Rates Today?

The Vilin Bio Med IPO Kostak Rate is ₹-.


What is Vilin Bio Med IPO Subject to Sauda Price Today?

The Vilin Bio Med IPO subject to sauda rates is ₹-.


Vilin Bio Med IPO Expected Returns?

The Vilin Bio Med expected return is -%.


Vilin Bio Med IPO GMP Live Rates day by day with Kotak rates.

DateGMPKostakSubject to
Today₹-₹-₹-
26 Jun₹-₹-₹-
22 Junv₹-v
21 Jun₹-₹-₹-
20 Jun₹-₹-₹-
19 Jun₹-₹-₹-
18 Jun₹-₹-₹-
15 Jun₹-₹-₹-
14 Jun₹-₹-₹-
13 Jun₹-₹-₹-


Vilin Bio Med IPO GMP aka Grey Market Premium FAQs:


What is Vilin Bio Med IPO GMP Today?

Vilin Bio Med IPO GMP is ₹- as of today.

What is Vilin Bio Med IPO Kostak Rate Today?

Vilin Bio Med IPO Kostak Rate is ₹- as of today.

What is Vilin Bio Med IPO Subject to Sauda Today?

Vilin Bio Med IPO Subject to Sauda is ₹- as of today.

What is Vilin Bio Med IPO Expected Returns?

Vilin Bio Med IPO Expected Returns is -%.

Disclaimer:

  • IPO Grey Market Premium (Vilin Bio Med IPO GMP) mention is valid for the specific date as mentioned in the header.
  • We are not buying and selling IPO forms on IPO Grey Market.
  • Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
  • Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.

Follow IPO Watch for the upcoming IPO news and their reviews, also keep following us on Twitter, Facebook, and Instagram. For our latest videos, subscribe to our YouTube channel.

Read Also:

Share the Post:
Facebook
Twitter
LinkedIn

Follow IPO Watch for the upcoming IPO news and their reviews, also keep following us on TwitterFacebook, and Instagram. For our latest videos, subscribe to our YouTube channel.


OPEN DEMAT ACCOUNT